Martindale Pharma re-launches methadone range in Scandinavia

UK specialty drugmaker Martindale Pharma has announced the re-launch of its methadone oral solution product in Scandinavia via its strategic partner Unimedic AB. Martindale’s methadone oral solution will be available for prescribers from April 1, 2016 in Norway and Sweden and May 1 in Finland.

The company says that it methadone oral solution represents a novel option for patients requiring opioid substitution therapy (OST) for the treatment of opioid addiction. The product is a 2mg/ml, orange flavored, sugar-free oral liquid and has been noted by prescribers and patients as the preferred treatment solution as existing products can contain large amounts of sugar/other flavours or unwanted additives like alcohol. The product comes in a range of small volumes where one bottle can be used as a single dose.

The re-launch of the product follows a change in excipients used in the formulation as well as the new appointment of Unimedic, as Martindale Pharma’s partner for this product range in Scandinavia.  This partnership expands a successfully established relationship with Unimedic AB for the marketing of Martindale Pharma’s sterile injection products.